Status:
UNKNOWN
A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy
Lead Sponsor:
University of British Columbia
Conditions:
Myocardial Infarction
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop and implement a critical pathway to identify patients with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator (ICD). This ...
Detailed Description
Despite improvements in both medical management and revascularization strategies, sudden death is still a significant complication in patients with ischemic cardiomyopathy. There is strong evidence to...
Eligibility Criteria
Inclusion
- acute ST segment elevation myocardial infarction (STEMI)
- candidate for percutaneous revascularization
- permanent residents of British Columbia, Canada
Exclusion
- patients with heart disease or a comorbid illness who have a documented life expectancy of less than 1 year
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01248702
Start Date
April 1 2012
End Date
May 1 2012
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6